Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/15281
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorReche Sainz, María Paloma-
dc.creatorGarcía de los Ríos, José Esteban-
dc.creatorJiménez Gómez, Pedro Antonio-
dc.creatorRojas Mendoza, Ana M.-
dc.creatorRotger, Rafael-
dc.date.accessioned2024-02-01T17:58:52Z-
dc.date.available2024-02-01T17:58:52Z-
dc.date.issued2022-09-
dc.identifier.citationM. Paloma Reche, José E. García de los Ríos, Pedro A. Jiménez, Ana M. Rojas, Rafael Rotger, gyrA Mutations Associated with Nalidixic Acid-Resistant Salmonellae from Wild Birds, 2002, Antimicrobial Agents and Chemotherapy, 3108-3109, 46, 9, doi:10.1128/aac.46.9.3108-3109.200-
dc.identifier.issn1098-6596-
dc.identifier.urihttp://hdl.handle.net/10637/15281-
dc.description.abstractThe emergence of quinolone-resistant isolates of salmonellae has been related to the use of antibiotics in veterinary medicine, which causes an important impact on the selection of resistance (2, 3, 8). It has also been demonstrated that veterinary clones possess the same mechanism of resistance as human clinical isolates (10). Quinolone resistance in salmonellae is mainly associated with mutations in the quinolone resistance- determining region (QRDR) of the gyrA and parC genesen_EN
dc.language.isoen-
dc.publisherAmerican Society for Microbiology-
dc.relation.ispartofAntimicrobial Agents and Chemotherapy-
dc.rightshttp://creativecommons.org/licenses/by/4.0/deed.es-
dc.rightsOpenAccess-
dc.subjectgyrA Mutationsen_EN
dc.subjectNalidixic Acid-Resistant Salmonellaeen_EN
dc.subjectWild Birdsen_EN
dc.titlegyrA Mutations Associated with Nalidixic Acid-Resistant Salmonellae from Wild Birdsen_EN
dc.typeArtículoen_EN
dc.identifier.doi10.1128/AAC.46.9.3108–3109.2002-
dc.relation.projectIDThis work has been supported by grant 13/99 of the Universidad San Pablo CEU.-
dc.centroUniversidad San Pablo-CEU-
Aparece en las colecciones: Facultad de Farmacia




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.